SCHEMBL6340968

SCHEMBL6340968

Oc1cc2ccccc2c(C2CCCCC2)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.44
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
MPI P34949 1/20 0.39
NQO2 P16083 1/20 0.39
CYP1B1 Q16678 1/20 0.38
IDO1 P14902 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.36
EPHX1 P07099 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4645332 0.82 CYP1B1 (0.43) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL6406321 0.79 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL6396905 0.77 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL3627014 0.76 CYP1B1 (0.39) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL28277177 0.72 CYP1A2 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL27986123 0.72 TRPM4 (0.47) TRPM4ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL8900082 0.72 NPC1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C19HSD17B10
SCHEMBL4646032 0.71 TDP1 (0.43) HSD17B10CYP1B1IDO1TDP1L3MBTL1
SCHEMBL29853814 0.71 TDP1 (0.43) HSD17B10CYP1B1IDO1TDP1L3MBTL1
SCHEMBL6346417 0.71 HDAC4 (0.40) TRPM4ALDH1A1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903114-B2 Derivatives of naphthalene with COMT inhibiting activity ORION CORPORATION (FI) 2005-06-07 US disclosed
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity ORION CORPORATION (FI) 2004-02-19 US disclosed
EP-1317411-A1 DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY ORION CORPORATION (FI) 2003-06-11 EP disclosed
WO-2002022551-A1 DERIVATIVES OF NAPHTHALENE WITH COMT INHIBITING ACTIVITY ORION CORPORATION (FI) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity COMT, CYP1A1, CYP1B1 TRPM4 4640/4885ALDH1A1 39/4885CYP1A2 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.